UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v126-v132

2015

Volltextzugriff (PDF)

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2019-12, Vol.30 (12), p.1884-1901

2019

Volltextzugriff (PDF)

SP-036: Immunity and immune toxicity: clinical management of immune checkpoint inhibition

Radiotherapy and oncology, 2017-03, Vol.122, p.21-21

Keilholz, U

2017

Volltextzugriff (PDF)

Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study

Annals of oncology, 2019-08, Vol.30 (8), p.1370-1380

2019

Volltextzugriff (PDF)

SP-047: Against the motion

Radiotherapy and oncology, 2015-02, Vol.114, p.27-28

Keilholz, U

2015

Volltextzugriff (PDF)

Neue Medikamente für die Behandlung der Kopf-Hals-Karzinome

Der Onkologe, 2014-02, Vol.20 (2), p.159-162

Keilholz, U.

2014

Volltextzugriff (PDF)

Behandlungsalgorithmen bei Patienten mit Kopf-Hals-Tumoren

Der Onkologe, 2014-02, Vol.20 (2), p.113-115

Keilholz, U.

2014

Volltextzugriff (PDF)

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2012-10, Vol.23 Suppl 7, p.vii86-vii91

2012

Volltextzugriff (PDF)

ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee

Annals of oncology, 2020-11, Vol.31 (11), p.1435-1448

2020

Volltextzugriff (PDF)

Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck

Annals of oncology, 2014-10, Vol.25 (10), p.2042-2047

2014

Volltextzugriff (PDF)

Role of TGF-β in melanoma

Current pharmaceutical biotechnology, 2011-12, Vol.12 (12), p.2165-2175

2011

Volltextzugriff (PDF)

ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee

Annals of oncology, 2020-11, Vol.31 (11), p.1449-1461

2020

Volltextzugriff (PDF)

Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings

Annals of oncology, 2011-08, Vol.22 (8), p.1812-1823

2011

Volltextzugriff (PDF)

TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)

Annals of oncology, 2015-03, Vol.26 (3), p.561-567

2015

Volltextzugriff (PDF)

Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance

Annals of oncology, 2015-01, Vol.26 (1), p.33-39

2015

Volltextzugriff (PDF)

FRI-01 The four melanomas

Digestive and liver disease, 2013-04, Vol.45, p.S240-S240

Keilholz, U

2013

Volltextzugriff (PDF)

Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany

BMC cancer, 2021-09, Vol.21 (1), p.1-1018, Article 1018

2021

Volltextzugriff (PDF)

The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)

Annals of oncology, 2011-08, Vol.22 (8), p.1878-1885

2011

Volltextzugriff (PDF)

appendix 2: Cutaneous melanoma (2): eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Melanoma)

Annals of oncology, 2016-09, Vol.27 (suppl 5), p.v136-v137

2016

Volltextzugriff (PDF)

Development and validation of a nomogram to predict recurrence and melanoma‐specific mortality in patients with negative sentinel lymph nodes

British journal of surgery, 2019-02, Vol.106 (3), p.217-225

2019

Volltextzugriff (PDF)

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Annals of oncology, 2014-03, Vol.25 (3), p.742-746

2014

Volltextzugriff (PDF)

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

Annals of oncology, 2014-03, Vol.25 (3), p.682-688

2014

Volltextzugriff (PDF)

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial

EBioMedicine, 2021-04, Vol.66, p.103327-103327, Article 103327

2021

Volltextzugriff (PDF)

Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)

European journal of cancer (1990), 2019-11, Vol.122, p.53-60

2019

Volltextzugriff (PDF)

Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence

European journal of cancer (1990), 2015-03, Vol.51 (4), p.514-521

2015

Volltextzugriff (PDF)

1 – 25 von 488

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(452)
Mit Volltextzugriff
(391)

Publikationsform

Sprache

Englisch
(423)
Deutsch
(63)

Erscheinungsjahr

n.n

Thema

Humans
(197)
Science & Technology
(189)
Life Sciences & Biomedicine
(187)
Oncology
(142)
Biological And Medical Sciences
(99)
Medical Sciences
(89)
Female
(79)
Male
(76)
Middle Aged
(74)
Aged
(67)
Adult
(65)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(42)
Pharmacology. Drug Treatments
(41)
Tumors
(41)
Melanoma - Therapy
(39)
Antineoplastic Agents
(37)
Immunotherapy
(35)
Melanoma - Pathology
(34)
Treatment Outcome
(32)
Dermatology
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(68)
Journal Of Clinical Oncology
(62)
European Journal Of Cancer
(37)
Melanoma Research
(30)
Journal Of Immunotherapy
(25)
International Journal Of Cancer
(16)
Onkologie
(15)
Der Onkologe
(14)
Aktuelle Urologie
(10)
European Journal Of Cancer Supplements
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

SP-036: Immunity and immune toxicity: clinical management of immune checkpoint inhibition

Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study

SP-047: Against the motion

Neue Medikamente für die Behandlung der Kopf-Hals-Karzinome

Behandlungsalgorithmen bei Patienten mit Kopf-Hals-Tumoren

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee

Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck

Role of TGF-β in melanoma

ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee

Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings

TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)

Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance

FRI-01 The four melanomas

Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany

The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)

appendix 2: Cutaneous melanoma (2): eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Melanoma)

Development and validation of a nomogram to predict recurrence and melanoma‐specific mortality in patients with negative sentinel lymph nodes

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial

Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)

Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence

Suchergebnisse filtern